Monoclonal antibody 3F8 can effect durable remissions in neuroblastoma patients refractory to chemotherapy: a phase II trial (Q70225496)
Jump to navigation
Jump to search
scientific article published on 01 January 1991
Language | Label | Description | Also known as |
---|---|---|---|
English | Monoclonal antibody 3F8 can effect durable remissions in neuroblastoma patients refractory to chemotherapy: a phase II trial |
scientific article published on 01 January 1991 |
Statements
Monoclonal antibody 3F8 can effect durable remissions in neuroblastoma patients refractory to chemotherapy: a phase II trial (English)
Kushner BH